脑微出血与血管内取栓后脑出血及功能结局的关系
该回顾性研究纳入513例前循环急性缺血性卒中行血管内取栓患者,分析取栓前T2*磁共振检测的脑微出血与术后颅内出血及3个月功能结局的关系。校正混杂因素后,脑微出血的存在或负荷与颅内出血及不良功能结局均无独立相关性,提示不应因此类患者排除再灌注治疗。
要点
- 取栓前脑微出血存在或负荷与颅内出血风险无独立相关性
- 脑微出血与3个月不良功能结局的关联在校正混杂因素后消失
- 不应仅因取栓前发现脑微出血而排除再灌注治疗
核心结论
- 校正混杂因素后,取栓前脑微出血的存在或负荷与颅内出血及不良功能结局均无显著相关性。
研究设计与样本
- 回顾性分析连续接受血管内取栓的前循环急性缺血性卒中患者513例。
- 由对功能结局不知情的神经放射科医生使用经验证量表在T2*磁共振上评估脑微出血。
主要发现
- 513例中281例(54.8%)功能结局不良,89例(17.3%)有至少1个脑微出血。
- 190例(37%)发生颅内出血,其中66例(12.9%)为症状性。
- 单变量分析中脑微出血负荷与不良结局相关(每增加1个脑微出血OR 1.18,95%CI 1.03-1.36,p=0.02)。
- 校正性别、年龄、卒中严重程度、高血压、糖尿病、心房颤动、既往抗血栓药物、静脉溶栓及再灌注状态后,关联不再显著(每增加1个脑微出血OR 1.05,95%CI 0.92-1.20,p=0.50)。
- 脑微出血的存在、负荷、位置或推测发病机制均与颅内出血无独立相关性。
关键数值与推荐
- 功能结局不良定义为3个月改良Rankin量表评分大于2。
- 脑微出血负荷以每增加1个脑微出血的比值比表示。
临床怎么用
- 对于取栓前磁共振发现脑微出血的急性缺血性卒中患者,不应仅因此排除再灌注治疗。
局限性
- 本研究为回顾性分析。
- 证据等级为Class II。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To determine whether pretreatment cerebral microbleeds (CMBs) presence and burden are correlated with an increased risk of intracranial hemorrhage (ICH) or poor functional outcome following endovascular thrombectomy (EVT) for acute ischemic stroke (AIS). METHODS: Consecutive patients treated by EVT for anterior circulation AIS were retrospectively analyzed. Experienced neuroradiologists blinded to functional outcomes rated CMBs on T2*-MRI using a validated scale. We investigated associations of CMB presence and burden with ICH and poor clinical outcome at 3 months (modified Rankin Scale score >2). RESULTS: Among 513 patients, 281 (54.8%) had a poor outcome and 89 (17.3%) had ≥1 CMBs. A total of 190 (37%) patients experienced ICH; 66 (12.9%) were symptomatic. CMB burden was associated with poor outcome in a univariable analysis (odds ratio [OR], 1.18; 95% confidence interval [CI], 1.03-1.36 per 1-CMB increase; p = 0.02), but significance was lost after adjustment for sex, age, stroke severity, hypertension, diabetes mellitus, atrial fibrillation, prior antithrombotic medication, IV thrombolysis, and reperfusion status (OR, 1.05; 95% CI, 0.92-1.20 per 1-CMB increase; p = 0.50). Results remained nonsignificant when taking into account CMB location or presumed underlying pathogenesis. CMB presence, burden, location, or presumed pathogenesis were not independently correlated with ICH. CONCLUSIONS: Poor functional outcome or ICH were not correlated with CMB presence or burden on pre-EVT MRI after adjustment for confounding factors. Excluding such patients from reperfusion therapies is unwarranted. CLASSIFICATION OF EVIDENCE: This study provides Class II evidence that in patients with AIS undergoing EVT, after adjustment for confounding factors, the presence of CMBs is not significantly associated with clinical outcome or the risk of ICH.
引用
- Derraz I, Cagnazzo F, Gaillard N, et al. Microbleeds, Cerebral Hemorrhage, and Functional Outcome After Endovascular Thrombectomy. Neurology. 2021. PMID: 33495380. doi:10.1212/WNL.0000000000011566
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。